Getein Biotech
Nanjing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Chinese IVD company focused on point-of-care testing platforms and reagents.
Diagnostics
Technology Platform
Integrated point-of-care testing platforms based on immunofluorescence and dry chemistry technologies for rapid quantitative detection of biomarkers.
Opportunities
Benefiting from China's healthcare decentralization policy and increasing demand for rapid diagnostics in primary care settings.
Risk Factors
Pricing pressure from volume-based procurement policies in China and rapid technological obsolescence requiring constant R&D investment.
Competitive Landscape
Faces intense competition in the fragmented Chinese POCT market from multinational corporations and numerous domestic companies, competing on menu breadth, cost, and distribution.